Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin-Reference-Cited by-同舟云学术

Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin

Published:2017-12-23 Issue:3 Volume:12 Page:603-613
ISSN:1873-9601
Container-title:Journal of Cell Communication and Signaling
language:en
Short-container-title:J. Cell Commun. Signal.

Author:

Mahmoud Salma Abdi,Ibrahim Mohammed Mohammed,Musa Ahmed Hago,Huang Yuhong,Zhang Jun,Wang Jingwen,Wei Yuanyi,Wang Li,Zhou Shunting,Xin Boyi,Xuan Wei,Tang Jianwu

Funder

National Natural Science Foundation of China

Financial Department of Liaoning Province

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://link.springer.com/article/10.1007/s12079-017-0411-9/fulltext.html

Reference46 articles.

1. Akutsu N et al (2010) Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma. World J Gastroenterol 16(28):3521–3528

2. Bao L et al (2013) MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Cancer Lett 337(2):226–236

3. Bayoglu IV et al (2015) Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers. Biomed Pharmacother 70:190–195

4. Chang M-C et al (2009) Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway. Biochem J 424:449–458

5. Chuang PT, McMahon AP (1999) Vertebrate hedgehog signalling modulated by induction of a hedgehog-binding protein. Nature 397(6720):617–621

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 6-O-endosulfatases in tumor metastasis: heparan sulfate proteoglycans modification and potential therapeutic targets;American Journal of Cancer Research;2024

2. Mesothelial cells regulate immune responses in health and disease: role for immunotherapy in malignant mesothelioma;Current Opinion in Immunology;2020-06